Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.6890
Dollar change
+0.0390
Percentage change
6.00
%
IndexRUT P/E- EPS (ttm)-0.52 Insider Own64.25% Shs Outstand112.18M Perf Week-2.02%
Market Cap87.33M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float45.31M Perf Month-11.07%
Income-66.00M PEG- EPS next Q- Inst Own9.95% Short Float8.51% Perf Quarter-33.11%
Sales0.00M P/S- EPS this Y- Inst Trans0.48% Short Ratio9.38 Perf Half Y-48.96%
Book/sh0.19 P/B3.68 EPS next Y- ROA-73.15% Short Interest3.85M Perf Year-68.10%
Cash/sh0.34 P/C2.04 EPS next 5Y- ROE-126.96% 52W Range0.56 - 3.10 Perf YTD-18.94%
Dividend Est.- P/FCF- EPS past 5Y- ROI-184.96% 52W High-77.77% Beta2.39
Dividend TTM- Quick Ratio2.15 Sales past 5Y-62.72% Gross Margin- 52W Low23.04% ATR (14)0.08
Dividend Ex-Date- Current Ratio2.15 EPS Y/Y TTM36.21% Oper. Margin0.00% RSI (14)46.50 Volatility8.53% 14.41%
Employees89 Debt/Eq0.56 Sales Y/Y TTM-100.00% Profit Margin- Recom2.00 Target Price7.00
Option/ShortNo / Yes LT Debt/Eq0.51 EPS Q/Q32.13% Payout- Rel Volume0.59 Prev Close0.65
Sales Surprise- EPS Surprise10.00% Sales Q/Q- EarningsMar 27 AMC Avg Volume410.78K Price0.69
SMA20-6.79% SMA50-3.53% SMA200-49.83% Trades Volume249,109 Change6.00%
Date Action Analyst Rating Change Price Target Change
Sep-08-23Initiated Robert W. Baird Outperform $7
Apr-27-22Initiated Evercore ISI In-line
Mar-27-24 10:52PM
04:41PM
Mar-07-24 10:32AM
Feb-15-24 11:29AM
08:00AM
08:00AM Loading…
Feb-13-24 08:00AM
Jan-30-24 12:27PM
08:00AM
Jan-19-24 02:32PM
Jan-18-24 08:00AM
Jan-03-24 08:00AM
Nov-20-23 06:00AM
Nov-13-23 06:50PM
Nov-08-23 08:30AM
Sep-07-23 09:35AM
08:00AM Loading…
Aug-29-23 08:00AM
Aug-10-23 05:50PM
08:00AM
Aug-09-23 08:00AM
Jul-28-23 10:19AM
Jul-27-23 04:30PM
Jul-17-23 12:23PM
08:00AM
Jun-22-23 01:57PM
12:22PM
08:00AM
May-09-23 08:00AM
May-03-23 06:53AM
Apr-24-23 02:09AM
Mar-28-23 08:00AM
07:50AM Loading…
Mar-27-23 07:50AM
Mar-21-23 08:00AM
Mar-20-23 08:00AM
Mar-02-23 08:00AM
Feb-01-23 07:40PM
Jan-19-23 02:04PM
Jan-05-23 08:00AM
Dec-31-22 07:35AM
Dec-02-22 08:00AM
05:30AM
Nov-10-22 07:30AM
Nov-03-22 08:00AM
Nov-01-22 09:00AM
Oct-30-22 10:27AM
Oct-24-22 08:00AM
Sep-19-22 09:00AM
Sep-13-22 08:00AM
Sep-12-22 08:00AM
Sep-01-22 08:00AM
Aug-15-22 04:39PM
Aug-12-22 04:19PM
Aug-11-22 08:00AM
Aug-04-22 07:00AM
Aug-02-22 01:43PM
08:00AM
Aug-01-22 08:00AM
Jul-25-22 11:57AM
Jun-02-22 07:00AM
May-12-22 09:31AM
May-09-22 07:42AM
May-05-22 07:00AM
May-02-22 08:00AM
Apr-28-22 08:00AM
Apr-12-22 08:43AM
Apr-07-22 08:14AM
Apr-06-22 04:43PM
Mar-28-22 08:00AM
Mar-24-22 04:05PM
Mar-21-22 07:00AM
Feb-11-22 09:28AM
Jan-13-22 10:53AM
Jan-12-22 09:21AM
08:10AM
Jan-10-22 07:00AM
Jan-04-22 07:00AM
Dec-23-21 04:45PM
Dec-07-21 07:25AM
Nov-28-21 07:55AM
Nov-18-21 04:05PM
Nov-16-21 12:41PM
Nov-11-21 04:42PM
01:59PM
06:43AM
06:30AM
Vaxxinity, Inc. is a biotechnology company that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. The company uses its synthetic peptide vaccine platform to harness the immune system and convert the body into its own 'drug factory', stimulating the production of antibodies with a therapeutic effect. Its current pipeline consists of five chronic disease candidates from early to late-stage development across multiple therapeutic areas including Alzheimer's, Parkinson's, migraine and hypercholesterolemia as well as a candidate for COVID-19 prevention. The company was founded by Louis G. Reese IV and Mei Mei Hu in 2014 and is headquartered in Exploration Park, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Prime Movers Lab Fund I LP10% OwnerSep 08 '23Sale1.6725,08941,8998,713,663Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 08 '23Sale1.6722,87238,196831,658Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 07 '23Sale1.7920,31236,3028,738,752Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 07 '23Sale1.7918,51633,092834,053Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 06 '23Sale1.885,3089,9918,759,064Sep 08 06:05 PM
Prime Movers Lab Fund I LP10% OwnerSep 06 '23Sale1.884,8399,108835,992Sep 08 06:05 PM
Diamandis PeterDirectorApr 26 '23Option Exercise0.63475,537300,816906,141May 02 10:46 AM